Dynamic 123I-BMIPP Single-Photon Emission Computed Tomography in Patients with Congestive Heart Failure: Effect of Angiotensin II Type-1 Receptor Blockade

Clinical Cardiology

Volumn 27, Issue 4, 2004, Pages 204-210

  Takeishi, Yasuchika ^a   Minamihaba, Osamu ^a   Yamauchi, Sou ^a   Arimoto, Takanori ^a   Hirono, Osamu ^a   Takahashi, Hiroki ^a   Akiyama, Hideyuki ^a   Miyamoto, Takuya ^a   Nitobe, Joji ^a   Nozaki, Naoki ^a   Tachibana, Hidetada ^a   Okuyama, Masaki ^a   Fukui, Akio ^a   Kubota, Isao ^a   Okada, Akio ^a   Takahashi, Kazuei ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

123I BMIPP; Angiotensin II receptor blockade; Fatty acid metabolism; Heart failure

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG ELIMINATION; FATTY ACID METABOLISM; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; INTRACELLULAR SPACE; MALE; PATHOPHYSIOLOGY; RADIOACTIVITY; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; TREATMENT OUTCOME; CASE CONTROL STUDY; DRUG ANTAGONISM; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CASE-CONTROL STUDIES; FATTY ACIDS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 4344596712     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960270406     Document Type: Article

References (28)

1. McFate SW: Epidemiology of congestive heart failure. Am J Cardiol 1985; 55(suppl):3A-8A
2. Wagoner LE, Walsh RA: The cellular pathophysiology of progression to heart failure. Curr Opin Cardiol 1997;11:237-244
3. Takeishi Y, Bhagwat A, Ball NA, Kirkpatrick DL, Periasamy M, Walsh RA: Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure. Am J Physiol 1999;276:H53-H62
4. Cohn JN, Tognoni G: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-1675
5. Sack MN, Kelly DP: The energy substrate switch during development of heart failure: Gene regulatory mechanisms. Int J Moll Med 1998;1:17-24
6. Barger PM, Kelly DP: Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanism. Am J Med Sci 1999;318:36-42
7. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP: Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996;94:2837-2842
8. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH: Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res 1998;83:969-979
9. Kataoka K, Nohara R, Hosokawa R, Hirai T, Okuda K, Li-Guang C, Fujibayashi Y, Fujita M, Konishi J, Sasayama S: Myocardial lipid metabolism in compensated and advanced stages of heart failure: Evaluation by canine pacing model with BMIPP. J Nucl Med 2001;42:124-129
10. Takeishi Y, Atsumi H, Fujiwara S, Fukui A, Okuyama M, Ito M, Kaneko K, Shishido T, Miyamoto T, Yuki K, Miyashita T, Yamaguchi S, Hirono O, Minamihaba O, Tomoike H: Angiotensin-converting enzyme inhibition improves cardiac 123I-BMIPP uptake in patients with congestive heart failure. J Nucl Med 2001;42(suppl):172P
11. Schelbert HR, Henze E, Schon HR, Keen R, Hansen H, Selin C, Huang SC, Barrio JR, Phelps ME: C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 1983;105:492-504
12. Yamamichi Y, Kusuoka H, Morishita K, Shirakami Y, Kurami M, Okano K, Itoh O, Nishimura T: Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043-1050
13. Fujiwara S, Takeishi Y, Atsumi H, Takahashi K, Tomoike H: Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 1997;38:175-180
14. Takeishi Y, Fujiwara S, Atsumi H, Takahashi K, Sukekawa K, Tomoike H: Iodine-123-BMIPP imaging in unstable angina: A guide for interventional strategy. J Nucl Med 1997;38:1407-1411
15. Fujiwara S, Takeishi Y, Tojo T, Yamaoka M, Nitobe J, Takahashi K, Tomoike H: Fatty acid imaging with 1231-15-(p-iodophenyl)-9-R, S-methylpentadecanoic acid in acute coronary syndrome. J Nucl Med 1999;40:1999-2006
16. Jun T, Hirono O, Kubota I, Okuyama M, Fukui A, Yamaki M, Tomoike H: Dobutamine stress echocardiography for the diagnosis of myocardial viability. Jpn HeartJ 2000;41:435-443
17. Schwartz K, Boheler KR, Bastie DDL, Lompre AM, Mercadier JJ: Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol 1992;262:R364-R369
18. Depre C, Vanoverschelde JLJ, Taegtmeyer H: Glucose for the heart. Circulation 1999;99:578-588
19. Nohara R: Lipid metabolism in the heart: Contribution of BMIPP to the diseased heart. Ann Nucl Med 2001;15:403-409
20. Schoonderwoerd K, Broekhoven-Schokker S, Hulsmann WC, Stam H: Involvement of lysosome-like particles in the metabolism of endogeneous myocardial triglycerides during ischemia/reperfusion. Uptake and degradation of triglycerides by lysosomes isolated from rat heart. Basic Res Cardiol 1990;85:153-163
21. Schoonderwoerd K, Broekhoven-Schokker S, Hulsmann WC, Stam H: Enhanced lipolysis of myocardial triglycerides during low-flow ischemia and anoxia in the isolated rat heart. Basic Res Cardiol 1989;84:165-173
22. Binas B, Danneberg H, McWhir J, Mullins L, Clark AJ: Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 1999;13:805-812
23. Schaap FG, Binas B, Danneberg H, van der Vusse GJ, Glatz JFC: Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. Circ Res 1999;85: 329-337
24. Kataoka K, Nohara R, Hirai T: Impaired fatty acid metabolism precedes left ventricular hypertrophy in pressure overload rats. J Nucl Cardiol 2001;8 (suppl):S88
25. Paul K, Ball NA, Dorn GW, Walsh RA: Left ventricular stretch stimulates angiotensin II-mediated phosphatidylinositol hydrolysis and protein kinase C ε isoforms translocation in adult guinea pig hearts. Circ Res 1997;81: 643-650
26. Fukuzawa S, Ozawa S, Inagaki M, Sugioka J, Daimon M, Kushida S: Angiotensin-converting enzyme inhibitor therapy affects myocardial fatty acid metabolism after acute myocardial infarction. J Nucl Cardiol 2000;7:23-28
27. 123I-BMIPP with myocardial imaging for the evaluation of the efficiency of drug therapy in patients with chronic heart failure. J Cardiac Fail 2001; 7:257-264
28. 123I-BMIPP for the diagnosis of coronary artery disease: Application to patients with diabetes mellitus and hyperlipidemia. Nucl Med Commun 1996;17:675-680